Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

TRDATRDA
19 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in ENTRADA THERAPEUTICS INC

Yes. Baker Bros. Advisors holds 5,072,730 shares of TRDA (Entrada Therapeutics), worth $37.3M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Baker Bros. Advisors has held TRDA in every 13F on record since Q4 2021, 19 quarterly filings. TRDA is 0.2% of Baker Bros. Advisors' reported 13F portfolio.

Current Value

$37.3M

Current Shares

5.1M

Total Value Change

-$43.2M

Total Shares Change

+368,311

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
5.1M
0.0%
$37.3M0.2%$7.36
0
2026-Q1
Unchanged
5.1M
0.0%
$64M0.4%$11.85
0
2025-Q4
Increased
5.1M
+4.3%
$52.1M0.3%$10.09
37
2025-Q3
Unchanged
4.9M
0.0%
$28.2M0.2%$5.84
0
2025-Q2
Unchanged
4.9M
0.0%
$32.7M0.3%$6.91
0
2025-Q1
Unchanged
4.9M
0.0%
$44M0.5%$9.56
0
2024-Q4
Unchanged
4.9M
0.0%
$84.1M0.9%$17.37
0
2024-Q3
Unchanged
4.9M
0.0%
$77.8M0.8%$16.45
0
2024-Q2
Unchanged
4.9M
0.0%
$69.3M0.9%$14.25
0
2024-Q1
Unchanged
4.9M
0.0%
$68.9M0.9%$14.17
0
2023-Q4
Unchanged
4.9M
0.0%
$73.4M0.8%$15.09
0
2023-Q3
Unchanged
4.9M
0.0%
$76.9M0.4%$15.80
0
2023-Q2
Unchanged
4.9M
0.0%
$73.7M0.4%$15.06
0
2023-Q1
Unchanged
4.9M
0.0%
$70.6M0.4%$15.03
0
2022-Q4
Unchanged
4.9M
0.0%
$65.8M0.4%$13.52
0
2022-Q3
Unchanged
4.9M
0.0%
$76.7M0.5%$15.54
0
2022-Q2
Increased
4.9M
+3.4%
$59.3M0.3%$12.94
36
2022-Q1
Unchanged
4.7M
0.0%
$44.2M0.3%$9.55
0
2021-Q4
New
4.7M
-
$80.5M0.4%$18.37
49

Other major holders of TRDA: WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used